ANDA cases will hit decade low, suggests H1 2021 data
Pfizer challenged the most ANDAs, Aurobindo filed the majority of applications and Williams & Connolly managed the most cases, according to new data
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: